[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vigil Neuroscience Inc (VIGL)

Vigil Neuroscience Inc (VIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vigil Neuroscience Inc 100 FORGE ROAD SUITE 700 WATERTOWN MA 02472 USA

www.vigilneuro.com Employees: 89 P: 857-254-4445

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Vigil Neuroscience Inc. is a microglia-focused therapeutics company. It focused on developing treatments for both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. Vigil Neuroscience Inc. is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 383,880
Enterprise Value, $K 344,860
Shares Outstanding, K 47,687
Float, K 39,099
% Float 81.99%
Short Volume Ratio 0.24
% of Insider Shareholders 18.01%
% of Institutional Shareholders 83.64%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -84,260 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -22,410 K
EBIT, $ -91,740 K
EBITDA, $ -92,830 K

Growth:

1-Year Return 103.80%
3-Year Return 1.64%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.49 on 05/07/25
Next Earnings Date 08/12/25
Earnings Per Share ttm -2.05
EPS Growth vs. Prev Qtr 14.04%
EPS Growth vs. Prev Year 2.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

VIGL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -111.70%
Return-on-Assets % -74.67%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 6.07
Book Value/Share 1.33
Interest Coverage -2.08
60-Month Beta 3.33
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.